NCT00075439
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +26 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Vipoma
Explore clinical trials studying Vipoma. Study availability and eligibility vary by location and protocol.
16 public trials
0 recruiting studies
Vipoma trial results
NCT00006368
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00005860
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +71 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Active, Not Recruiting
DOTATOC PET/CT for Imaging NET Patients
NCT03583528
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +66 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada